Janus Henderson Group PLC reduced its setting in shares of West Pharmaceutical Solutions, Inc. (NYSE: WST– Free Report) by 4.2% throughout the fourth quarter, according to its newest declaring with the Stocks and Exchange Payment. The institutional financier owned 9,792 shares of the medical tools distributor’s supply after marketing 434 shares during the quarter. […]
Janus Henderson Group PLC decreased its placement in shares of West Drug Services, Inc. (NYSE: WST– Free Report) by 4.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Compensation. The institutional financier had 9,792 shares of the clinical tools provider’s stock after offering 434 shares throughout the quarter. Janus Henderson Group PLC’s holdings in West Drug Solutions were worth $3,209,000 at the end of the most recent quarter. A variety of various other hedge funds and other institutional capitalists have likewise made adjustments to their positions in WST. Fiera Capital Corp increased its holdings in shares of West Pharmaceutical Providers by 13.2% in the fourth quarter. Fiera Resources Corp currently owns 140,893 shares of the medical tools provider’s supply valued at $46,151,000 after buying an additional 16,418 shares in the last quarter. Trust Point Inc. lifted its position in West Pharmaceutical Services by 321.0% during the fourth quarter. Depend on Point Inc. now possesses 3,183 shares of the medical tools provider’s supply valued at $1,043,000 after getting an added 2,427 shares throughout the last quarter. Savant Resources LLC increased its stake in West Drug Providers by 15.0% in the fourth quarter. Sage Funding LLC currently owns 1,003 shares of the medical tools vendor’s stock valued at $329,000 after obtaining an added 131 shares in the last quarter. Tokio Marine Property Administration Co. Ltd. grew its holdings in West Pharmaceutical Services by 904.2% in the fourth quarter. Tokio Marine Property Monitoring Co. Ltd. currently possesses 21,941 shares of the medical instruments supplier’s stock worth $7,187,000 after buying an extra 19,756 shares during the last quarter. Finally, National Riches Monitoring Group LLC acquired a brand-new position in shares of West Pharmaceutical Services during the 4th quarter worth $706,000. Institutional financiers own 93.90% of the business’s supply. Experts Set New Rate Targets A variety of experts have recently evaluated in on the firm. KeyCorp lowered their rate objective on West Pharmaceutical Solutions from $470.00 to $325.00 and established an “overweight” ranking for the company in a study record on Friday, February 14th. Evercore ISI started insurance coverage on West Pharmaceutical Solutions in a record on Tuesday, March 18th. They provided an “outperform” ranking and a $275.00 price target for the company. Stephens upgraded shares of West Pharmaceutical Services to a “strong-buy” ranking in a report on Monday, April 21st. StockNews.com decreased shares of West Pharmaceutical Providers from a “buy” rating to a “hold” rating in a study report on Thursday, February 27th. Ultimately, Deutsche Financial institution Aktiengesellschaft upgraded shares of West Pharmaceutical Solutions from a “hold” ranking to a “get” score and set a $250.00 target cost for the firm in a study note on Friday, February 14th. 2 financial investment analysts have ranked the stock with a hold rating, six have actually appointed a buy rating and one has actually provided a solid buy ranking to the company’s supply. According to MarketBeat, the business currently has a consensus rating of “Moderate Buy” and a consensus cost target of $332.50. West Drug Services Trading Up 0.2% West Drug Services supply opened at $217.00 on Tuesday. The company has a market cap of $15.59 billion, a PE proportion of 32.44, a P/E/G proportion of 6.74 and a beta of 1.14. West Drug Services, Inc. has a year low of $187.43 and a twelve month high of $355.66. The stock’s 50 day basic moving average is $214.75 and its two-hundred day straightforward relocating standard is $273.88. The business has a present ratio of 2.79, a fast ratio of 2.23 and a debt-to-equity ratio of 0.08. West Drug Solutions (NYSE: WST– Break Out Record) last announced its quarterly revenues results on Thursday, April 24th. The medical tools provider reported $1.45 incomes per share for the quarter, beating the consensus price quote of $1.22 by $0.23. The company had revenue of $698.00 million during the quarter, contrasted to analyst price quotes of $685.24 million. West Pharmaceutical Services had a return on equity of 18.60% and an internet margin of 17.03%. West Pharmaceutical Provider’s profits for the quarter was up.4% compared to the very same quarter last year. Throughout the very same quarter in the previous year, business gained $1.56 EPS. Analysts prepare for that West Drug Providers, Inc. will certainly upload 6.62 revenues per share for the current year. West Pharmaceutical Provider Reveals Returns Business also recently announced a quarterly returns, which will certainly be paid on Wednesday, August sixth. Shareholders of document on Wednesday, July 30th will be paid a returns of $0.21 per share. The ex-dividend date of this dividend is Wednesday, July 30th. This stands for a $0.84 reward on an annualized basis and a reward return of 0.39%. West Pharmaceutical Provider’s returns payment ratio is presently 13.19%. West Pharmaceutical Solutions Account (Free Report) West Drug Solutions, Inc styles, makes, and offers containment and distribution systems for injectable medications and medical care products in the Americas, Europe, the Center East, Africa, and the Asia Pacific. It operates in 2 segments, Proprietary Products and Contract-Manufactured Products. Better Checking out Intend to see what other hedge funds are holding WST? See HoldingsChannel.com to get the most recent 13F filings and insider professions for West Drug Solutions, Inc. (NYSE: WST– Free Report ). Receive Information & Scores for West Drug Solutions Daily – Enter your e-mail address listed below to receive a concise everyday summary of the current news and experts’ rankings for West Drug Solutions and associated firms with MarketBeat.com’s FREE day-to-day email e-newsletter.
Janus Henderson Group PLC decreased its position in shares of West Drug Services, Inc. (NYSE: WST– Free Record) by 4.2% throughout the 4th quarter, according to its most current filing with the Securities and Exchange Compensation. Fiera Funding Corp increased its holdings in shares of West Pharmaceutical Services by 13.2% in the Fourth quarter. West Drug Solutions Trading Up 0.2% West Pharmaceutical Solutions stock opened up at $217.00 on Tuesday. West Pharmaceutical Providers Account (Free Report) West Pharmaceutical Providers, Inc layouts, makes, and sells control and distribution systems for injectable medications and medical care products in the Americas, Europe, the Center East, Africa, and the Asia Pacific. Receive News & Scores for West Drug Services Daily – Enter your email address listed below to obtain a concise day-to-day recap of the most recent news and analysts’ scores for West Drug Services and related business with MarketBeat.com’s FREE daily e-mail newsletter.